This is a community-generated profile. If you would like to claim it, please .
developing a new class of therapeutics to slow, halt or reverse diseases of aging
Unity Biotechnology Funding
$116M
11 round
Unity Biotechnology is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $116M. Their most recent funding was raised on October 28, 2016.
Funding Rounds
B
$116000000
Investors of Unity Biotechnology
Value investor in Public and Private Companies; founder, cofounder & cocrerator
George Singer
Building https://simulavr.com
The Longevity Fund
Investing in Human Longevity
Investor at @Founders Fund and early employee at @SpaceX. Studied at @Stanford University and @Cornell University.
Baillie Gifford
Rounds
B
WuXi PharmaTech (Cayman)
Rounds
B
Mayo Clinic Ventures
Commercializes IP from Mayo Clinic
Rounds
B
ARCH Venture Partners
Rounds
B
Fidelity Management and Research Company
Rounds
B